T. Rowe Price Investment Management, Inc. 13D and 13G filings for Cytokinetics, Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-07 10:37 am Purchase |
2025-04-30 | 13G | Cytokinetics, Incorporated CYTK |
T. Rowe Price Investment Management, Inc. | 13,420,144 11.300% |
3,730,157 (+38.49%) |
Filing |
| 2024-11-14 1:28 pm Purchase |
2024-09-30 | 13G | Cytokinetics, Incorporated CYTK |
T. Rowe Price Investment Management, Inc. | 9,689,987 8.200% |
9,689,987 (New Position) |
Filing |